-
Glembatumumab vedotin (also
known as CDX-011 and CR011-vcMMAE) is an antibody-drug
conjugate (ADC) that
targets cancer cells expressing transmembrane...
-
found in
aggressive melanoma, glioma,
breast cancer and
other tumours:
Glembatumumab (CR011, CDX-011),
investigated for the
treatment of
breast cancer and...
-
inhibitor BSI 201, NK012. A
novel antibody-drug
conjugate known as
glembatumumab vedotin (CDX-011),
which targets the
protein GPNMB, has also
shown encouraging...
-
itself but
predominantly affects cancer cells if used in
conjugates like
glembatumumab vedotin. A
chelator for
binding a
radioisotope can be attached. Pendetide...
-
chimeric carbonic anhydrase 9 (CA-IX)
clear cell
renal cell
carcinoma Glembatumumab vedotin mab
human GPNMB melanoma,
breast cancer Glofitamab Columvi BsAb...
-
Cancer PM00104
Zalypsis Nudibranch Alkaloid DNA-Binding 2/3
Cancer Glembatumumab Vedotin (CDX-011) N/A
Mollusk Antibody Drug
Conjugate (MM Auristatin...
-
glafenine (INN)
glaspimod (INN)
glaziovine (INN)
Gleevec glemanserin (INN)
glembatumumab (USAN, INN)
glenvastatin (INN)
Gleolan gleptoferron (INN)
Gliadel Wafer...
-
GPNMB is the
target of the
antibody glembatumumab (CR011)
which is used in the antibody-drug
conjugate glembatumumab vedotin (CDX-011, CR011-vcMMAE) which...
-
Enfortumab vedotin Enoti****ab§ Figitumumab§ Flanvotumab§ Ganitumab†
Glembatumumab vedotin† Intetumumab§
Ipilimumab Iratumumab§
Istiratumab Icru****ab§...
-
Enfortumab vedotin Enoti****ab§ Figitumumab§ Flanvotumab§ Ganitumab†
Glembatumumab vedotin† Intetumumab§
Ipilimumab Iratumumab§
Istiratumab Icru****ab§...
